Effectiveness of desloratadine 5 mg once daily in patients with symptoms of seasonal allergic rhinitis: results of a Canadian multicenter, open-label trial.
Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study.
Autorzy:
KeithPK; Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, L8N 3Z5, Canada. Cowan J; Division of Infectious Diseases, Department of Medicine, Department of Biochemistry, Microbiology, and Immunology; Centre for Infection, Immunity and Inflammation, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, K1H 8M5, Canada. Kanani A; Division of Allergy and Clinical Immunology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada. Kim H; Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, L8N 3Z5, Canada.; Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, ON, N6A 5A5, Canada. Lacuesta G; Department of Medicine, Dalhousie University, Halifax, NS, B3H 2Y9, Canada. Lee JK; Chair of Toronto Allergists and Evidence Based Medical Educator, Toronto, ON, M5G 1E2, Canada. Chen J; Takeda Development Center Americas, Inc., Cambridge, MA, 02139, USA. Park M; Takeda Development Center Americas, Inc., Cambridge, MA, 02139, USA. Gladiator A; Glattpark‑Opfikon, Takeda Pharmaceuticals International AG, Thurgauerstrasse 130, 8152, Zurich, Switzerland. .
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis.
Autorzy:
Mendivil J; Takeda Pharmaceuticals International AG, Zurich, Switzerland. DerSarkissian M; Analysis Group, Inc., Boston, MA, USA. Banerji A; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Diwakar L; Department of Immunology, University Hospitals of North Midlands, Stoke-on-Trent, UK. Katelaris CH; Campbelltown Hospital, Western Sydney University, Campbelltown, NSW, Australia. KeithPK; McMaster University, Hamilton, ON, Canada. Kim H; McMaster University, Hamilton, ON, Canada.; Department of Medicine, Western University, London, ON, Canada. Lacuesta G; Halifax Allergy and Asthma Associates, Halifax, NS, Canada. Magerl M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany. Slade C; Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Melbourne, VIC, Australia. Smith WB; Department of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, SA, Australia. Choudhry Z; Takeda Development Center Americas, Lexington, MA, USA. Simon A; Takeda Development Center Americas, Lexington, MA, USA. . Sarda SP; Takeda Development Center Americas, Lexington, MA, USA. Busse PJ; Division of Allergy and Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study.
Autorzy:
KeithPK; Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, L8N 3Z5, Canada. Cowan J; Division of Infectious Diseases, Department of Medicine; Department of Biochemistry, Microbiology, and Immunology; Centre for Infection, Immunity and Inflammation, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, K1H 8M5, Canada. Kanani A; Division of Allergy and Clinical Immunology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada. Kim H; Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, L8N 3Z5, Canada.; Division of Clinical Immunology and Allergy, Department of Medicine, Western University, London, ON, N6A 5A5, Canada. Lacuesta G; Department of Medicine, Dalhousie University, Halifax, NS, B3H 2Y9, Canada. Lee JK; Chair of Toronto Allergists and Evidence Based Medical Educator, Toronto, ON, M5G 1E2, Canada. Chen J; Takeda Development Center Americas, Inc., Cambridge, MA, 02139, USA. Park M; Takeda Development Center Americas, Inc., Cambridge, MA, 02139, USA. Gladiator A; Glattpark-Opfikon , Takeda Pharmaceuticals International AG, Thurgauerstrasse 130, 8152, Zurich, Switzerland. .
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Autorzy:
Lumry WR; AARA Research Center, 10100 N. Central Expressway, Suite 100, Dallas, TX, 75231, USA. . Zuraw B; Department of Medicine, UC San Diego, La Jolla, CA, USA. Cicardi M; University of Milan, Milan, Italy. Craig T; Penn State University College of Medicine, Hershey, PA, USA. Anderson J; Clinical Research Center of Alabama, Birmingham, AL, USA. Banerji A; Massachusetts General Hospital, Boston, MA, USA. Bernstein JA; University of Cincinnati College of Medicine and Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA. Caballero T; Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network On Rare Diseases (CIBERER U754), Madrid, Spain. Farkas H; Hungarian Angioedema Reference Center, 3Rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Gower RG; Maryclif Clinical Research, Spokane, WA, USA. KeithPK; McMaster University, Hamilton, ON, USA. Levy DS; UC Irvine, Orange, CA, USA. Li HH; Institute for Asthma and Allergy, Chevy Chase, MD, USA. Magerl M; Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Berlin, Germany. Manning M; Medical Research of Arizona, Scottsdale, AZ, USA. Riedl MA; Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, USA. Lawo JP; CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg, Germany. Prusty S; CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg, Germany. Machnig T; CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg, Germany. Longhurst H; University College Hospital, London, UK.; Auckland District Health Board, Auckland, New Zealand.
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Autorzy:
Lumry WR; AARA Research Center, 10100 N. Central Expressway, Suite 100, Dallas, TX, 75231, USA. . Zuraw B; Department of Medicine, UC San Diego, La Jolla, CA, USA. Cicardi M; University of Milan, Milan, Italy. Craig T; Penn State University College of Medicine, Hershey, PA, USA. Anderson J; Clinical Research Center of Alabama, Birmingham, AL, USA. Banerji A; Massachusetts General Hospital, Boston, MA, USA. Bernstein JA; University of Cincinnati College of Medicine and Bernstein Clinical Research Center, LLC, Cincinnati, OH, USA. Caballero T; Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network On Rare Diseases (CIBERER U754), Madrid, Spain. Farkas H; Hungarian Angioedema Reference Center, 3Rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary. Gower RG; Marycliff Clinical Research, Spokane, WA, USA. KeithPK; McMaster University, Hamilton, ON, USA. Levy DS; UC Irvine, Orange, CA, USA. Li HH; Institute for Asthma and Allergy, Chevy Chase, MD, USA. Magerl M; Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Berlin, Germany. Manning M; Medical Research of Arizona, Scottsdale, AZ, USA. Riedl MA; Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, USA. Lawo JP; CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg, Germany. Prusty S; CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg, Germany. Machnig T; CSL Behring GmbH, Emil-von-Behring-Strasse 76, Marburg, Germany. Longhurst H; University College Hospital, London, UK.; Auckland District Health Board, Auckland, New Zealand.
Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review.
Autorzy:
Wong MM; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON Canada. KeithPK; Department of Medicine, Division of Clinical Immunology and Allergy, McMaster University, Health Sciences Centre 3V47, 1280 Main St West, Hamilton, ON L8S 4K1 Canada.
Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review.
Autorzy:
Levy D; Division of Basic and Clinical Immunology, University of California, 705 W. La Veta Ave STE 101, Orange, CA 92868 USA. Craig T; Departments of Medicine and Pediatrics, Penn State University, Hershey, PA USA. KeithPK; Department of Medicine, McMaster University, Hamilton, ON Canada. Krishnarajah G; CSL Behring, King of Prussia, PA USA.; Present Address: Seqirus-A CSL Company, Summit, NJ USA. Beckerman R; Maple Health Group LLC, NY, USA. Prusty S; CSL Behring, Marburg, Germany.
An Appraisal of Developments in Allium Sulfur Chemistry: Expanding the Pharmacopeia of Garlic.
Autorzy:
Rose P; School of Biosciences, University of Nottingham, Loughborough, Leicestershire LE12 5RD, UK.; School of Pharmacy and State key Lab. of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China. Moore PK; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore. Whiteman M; Medical School Building, St Luke's Campus, Magdalen Road, Exeter EX1 2LU, UK. Zhu YZ; School of Pharmacy and State key Lab. of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
